Order Article Reprints

Anindita J, Tanaka H, Yamakawa T, Sato Y, Matsumoto C, Ishizaki K, Oyama T, Suzuki S, Ueda K, Higashi K, et al. The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles. Pharmaceutics. 2024; 16(2):181. https://doi.org/10.3390/pharmaceutics16020181

Anindita, Jessica, Hiroki Tanaka, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Taiji Oyama, Satoko Suzuki, Keisuke Ueda, Kenjirou Higashi, and et al. 2024. "The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles" Pharmaceutics 16, no. 2: 181. https://doi.org/10.3390/pharmaceutics16020181

Anindita, J., Tanaka, H., Yamakawa, T., Sato, Y., Matsumoto, C., Ishizaki, K., Oyama, T., Suzuki, S., Ueda, K., Higashi, K., Moribe, K., Sasaki, K., Ogura, Y., Yonemochi, E., Sakurai, Y., Hatakeyama, H., & Akita, H. (2024). The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles. Pharmaceutics, 16(2), 181. https://doi.org/10.3390/pharmaceutics16020181